{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:40:10Z","timestamp":1769154010874,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Novartis Pharma AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12890-017-0372-z","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T04:30:05Z","timestamp":1485837005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Le Gros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Decuyp\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bourdeix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00ebtan","family":"Desl\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"issue":"6","key":"372_CR1","first-page":"806","volume":"5","author":"HD Seth","year":"2013","unstructured":"Seth HD, Sultan S, Gotfried MH. Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease. J Thorac Dis. 2013;5(6):806\u201314.","journal-title":"J Thorac Dis"},{"key":"372_CR2","unstructured":"Global Strategy for the Diagnosis, Management, and Prevention of COPD, GOLD 2016."},{"issue":"4","key":"372_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.97.10040815","volume":"10","author":"G Boyd","year":"1997","unstructured":"Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1997;10(4):815\u201321.","journal-title":"Eur Respir J"},{"issue":"5","key":"372_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0954-6111(95)90008-X","volume":"89","author":"M Cazzola","year":"1995","unstructured":"Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D\u2019Amato G. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose\u2013response study. Respir Med. 1995;89(5):357\u201362.","journal-title":"Respir Med"},{"issue":"4","key":"372_CR5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1378\/chest.121.4.1058","volume":"121","author":"A Rossi","year":"2002","unstructured":"Rossi A, Kristufek P, Levine BE, Thomson MH, Till D, Kottakis J, Della Cioppa G, Formoterol in Chronic Obstructive Pulmonary Disease IISG. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest. 2002;121(4):1058\u201369.","journal-title":"Chest"},{"issue":"7","key":"372_CR6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/thx.50.7.750","volume":"50","author":"CS Ulrik","year":"1995","unstructured":"Ulrik CS. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Thorax. 1995;50(7):750\u20134.","journal-title":"Thorax"},{"issue":"8","key":"372_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2011-201458","volume":"67","author":"P Albert","year":"2012","unstructured":"Albert P, Agusti A, Edwards L, Tal-Singer R, Yates J, Bakke P, Celli BR, Coxson HO, Crim C, Lomas DA, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 2012;67(8):701\u20138.","journal-title":"Thorax"},{"issue":"6","key":"372_CR8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.rmed.2004.11.009","volume":"99","author":"M Molimard","year":"2005","unstructured":"Molimard M, Bourcereau J, Le Gros V, Bourdeix I. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD. Respir Med. 2005;99(6):695\u2013702.","journal-title":"Respir Med"},{"key":"372_CR9","unstructured":"Global Strategy for the Diagnosis, Management, and Prevention of COPD, GOLD 2014."},{"key":"372_CR10","doi-asserted-by":"crossref","unstructured":"Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PMA, Chavannes N, Dillard T, Fahy B, Fein A, Heffner J, Lareau S, Meek P, Martinez F, McNicholas W, Muris J, Austegard E, Pauwels R, Rennard S, Rossi A, Siafakas N, Tiep B, Vestbo J, Wouters E, ZuWallack R. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper. Eur Respir J. 2004;23:932\u2013946.","DOI":"10.1183\/09031936.04.00014304"},{"issue":"5","key":"372_CR11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948\u201368.","journal-title":"Eur Respir J"},{"issue":"7","key":"372_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","volume":"14","author":"C Pitzalis","year":"2014","unstructured":"Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol. 2014;14(7):447\u201362.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"372_CR13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/thoraxjnl-2013-204119","volume":"69","author":"SS Kon","year":"2014","unstructured":"Kon SS, Dilaver D, Mittal M, Nolan CM, Clark AL, Canavan JL, Jones SE, Polkey MI, Man WD. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax. 2014;69(9):793\u20138.","journal-title":"Thorax"},{"key":"372_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-12-6","volume":"12","author":"NA Hanania","year":"2011","unstructured":"Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011;12:6.","journal-title":"Respir Res"},{"issue":"5","key":"372_CR15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.123.5.1441","volume":"123","author":"D Tashkin","year":"2003","unstructured":"Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003;123(5):1441\u20139.","journal-title":"Chest"},{"issue":"2","key":"372_CR16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"7","key":"372_CR17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S2213-2600(13)70086-9","volume":"1","author":"PMA Calverley","year":"2013","unstructured":"Calverley PMA, Albert P, Walker PP. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. The Lancet Respiratory Medicine. 2013;1(7):564\u201373.","journal-title":"The Lancet Respiratory Medicine"},{"issue":"4","key":"372_CR18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.10-2974","volume":"140","author":"NA Hanania","year":"2011","unstructured":"Hanania NA, Celli BR, Donohue JF, Martin UJ. Bronchodilator reversibility in COPD. Chest. 2011;140(4):1055\u201363.","journal-title":"Chest"},{"issue":"3","key":"372_CR19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1378\/chest.14-0810","volume":"146","author":"R Pellegrino","year":"2014","unstructured":"Pellegrino R, Brusasco V. Point: Is an increase in FEV (1) and\/or FVC >\/= 12% of control and >\/= 200\u00a0mL the best way to assess positive bronchodilator response? Yes. Chest. 2014;146(3):536\u20137.","journal-title":"Chest"},{"issue":"3","key":"372_CR20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1378\/chest.14-0437","volume":"146","author":"JE Hansen","year":"2014","unstructured":"Hansen JE, Porszasz J. Counterpoint: Is an increase in FEV (1) and\/or FVC >\/= 12% of control and >\/= 200\u00a0mL the best way to assess positive bronchodilator response? No. Chest. 2014;146(3):538\u201341.","journal-title":"Chest"},{"issue":"5","key":"372_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/thx.2006.072348","volume":"62","author":"LP McGarvey","year":"2007","unstructured":"McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA, Committee TCE. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):411\u20135.","journal-title":"Thorax"},{"issue":"4","key":"372_CR22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rmed.2011.10.009","volume":"106","author":"LP McGarvey","year":"2012","unstructured":"McGarvey LP, Magder S, Burkhart D, Kesten S, Liu D, Manuel RC, Niewoehner DE. Cause-specific mortality adjudication in the UPLIFT (R) COPD trial: findings and recommendations. Respir Med. 2012;106(4):515\u201321.","journal-title":"Respir Med"},{"issue":"2","key":"372_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1183\/09031936.00045810","volume":"37","author":"O Kornmann","year":"2011","unstructured":"Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C, Kramer B. Inlight- study investigators: Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J. 2011;37(2):273\u20139.","journal-title":"Eur Respir J"},{"issue":"4","key":"372_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1183\/09031936.00191810","volume":"38","author":"R Buhl","year":"2011","unstructured":"Buhl R, Dunn LJ, Disdier C, Lassen C, Amos C, Henley M, Kramer B. Intensity study investigators: Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J. 2011;38(4):797\u2013803.","journal-title":"Eur Respir J"},{"issue":"1","key":"372_CR25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/15412555.2013.781996","volume":"11","author":"WD Van Dijk","year":"2014","unstructured":"Van Dijk WD, Gupta N, Tan WC, Bourbeau J. Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. Copd. 2014;11(1):113\u201320.","journal-title":"Copd"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-017-0372-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:27:10Z","timestamp":1692664030000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-017-0372-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1186\/s12890-017-0372-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,31]]},"article-number":"25"}}